
### [MONDO:0018117](http://purl.obolibrary.org/obo/MONDO_0018117)
**Label:** disorder of phospholipids, sphingolipids and fatty acids biosynthesis

**Subclasses:** [MONDO:0018118](http://purl.obolibrary.org/obo/MONDO_0018118) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with central nervous system predominant involvement), [MONDO:0020504](http://purl.obolibrary.org/obo/MONDO_0020504) (genetic recurrent myoglobinuria), [MONDO:0018119](http://purl.obolibrary.org/obo/MONDO_0018119) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with peripheral nerves predominant involvement), [MONDO:0009739](http://purl.obolibrary.org/obo/MONDO_0009739) (neurodegeneration with brain iron accumulation 2a), [MONDO:0017998](http://purl.obolibrary.org/obo/MONDO_0017998) (PLA2G6-associated neurodegeneration), [MONDO:0015611](http://purl.obolibrary.org/obo/MONDO_0015611) (neutral lipid storage disease), [MONDO:0018213](http://purl.obolibrary.org/obo/MONDO_0018213) (hereditary sensory and autonomic neuropathy type 1), [MONDO:0012189](http://purl.obolibrary.org/obo/MONDO_0012189) (Amish infantile epilepsy syndrome), [MONDO:0018274](http://purl.obolibrary.org/obo/MONDO_0018274) (GM3 synthase deficiency), [MONDO:0018120](http://purl.obolibrary.org/obo/MONDO_0018120) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement), [MONDO:0008922](http://purl.obolibrary.org/obo/MONDO_0008922) (Sengers syndrome), [MONDO:0009319](http://purl.obolibrary.org/obo/MONDO_0009319) (pantothenate kinase-associated neurodegeneration), 

**Corr. equiv. classes:** [Orphanet:370933](http://www.orpha.net/ORDO/Orphanet_370933), [Orphanet:165](http://www.orpha.net/ORDO/Orphanet_165), [Orphanet:352309](http://www.orpha.net/ORDO/Orphanet_352309), [Orphanet:157850](http://www.orpha.net/ORDO/Orphanet_157850), [Orphanet:329303](http://www.orpha.net/ORDO/Orphanet_329303), [OMIM:256600](http://purl.obolibrary.org/obo/OMIM_256600), [Orphanet:171714](http://www.orpha.net/ORDO/Orphanet_171714), [Orphanet:352306](http://www.orpha.net/ORDO/Orphanet_352306), [Orphanet:99845](http://www.orpha.net/ORDO/Orphanet_99845), [Orphanet:35069](http://www.orpha.net/ORDO/Orphanet_35069), [OMIM:609056](http://purl.obolibrary.org/obo/OMIM_609056), [OMIM:234200](http://purl.obolibrary.org/obo/OMIM_234200), [Orphanet:36386](http://www.orpha.net/ORDO/Orphanet_36386), [Orphanet:352312](http://www.orpha.net/ORDO/Orphanet_352312), [OMIM:212350](http://purl.obolibrary.org/obo/OMIM_212350), [Orphanet:1369](http://www.orpha.net/ORDO/Orphanet_1369), 

**Class expressions from DL-Learner:**

- [HP:0002376](http://purl.obolibrary.org/obo/HP_0002376) (Developmental regression) and (not ([HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system))) 34.86%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 27.56%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 25.52%
- Thing 25.51%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 25.51%
- [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 24.72%
- [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 24.43%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 23.81%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 22.99%
- [HP:0012547](http://purl.obolibrary.org/obo/HP_0012547) (Abnormal involuntary eye movements) 22.31%
- [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 22.10%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 21.08%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) 19.66%
- [HP:0000496](http://purl.obolibrary.org/obo/HP_0000496) (Abnormality of eye movement) 19.45%
- [HP:0001252](http://purl.obolibrary.org/obo/HP_0001252) (Muscular hypotonia) 18.98%


